Scarica l'app Stockscreener
190.38
1.93%
-3.75
Dopo l'orario di chiusura:
190.38
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché THC Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$194.13
Aprire:
$196.11
Volume 24 ore:
1.24M
Relative Volume:
0.96
Capitalizzazione di mercato:
$16.40B
Reddito:
$21.46B
Utile/perdita netta:
$2.65B
Rapporto P/E:
9.8995
EPS:
19.2312
Flusso di cassa netto:
$3.35B
1 W Prestazione:
+3.88%
1M Prestazione:
-4.49%
6M Prestazione:
-7.25%
1 anno Prestazione:
+27.72%
Intervallo 1D:
$188.88
$198.43
Intervallo di 1 settimana:
$177.41
$198.43
Portata 52W:
$146.60
$247.21
Tenet Healthcare Corp Stock (THC) Company Profile
Nome
Tenet Healthcare Corp
Settore
Industria
Telefono
469-893-2200
Indirizzo
14201 DALLAS PARKWAY, DALLAS, TX
Compare THC vs HCA, DVA, FMS, EHC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
THC
Tenet Healthcare Corp
|
190.38 | 16.40B | 21.46B | 2.65B | 3.35B | 19.23 |
HCA
Hca Healthcare Inc
|
435.19 | 96.54B | 76.39B | 7.81B | 7.93B | 29.08 |
DVA
Davita Inc
|
198.65 | 12.75B | 13.64B | 1.05B | 1.31B | 9.555 |
FMS
Fresenius Medical Care Ag Adr
|
22.03 | 11.83B | 22.18B | 1.36B | 2.00B | 1.9216 |
EHC
Encompass Health Corp
|
106.10 | 10.53B | 6.07B | 793.80M | 464.40M | 5.9914 |
Tenet Healthcare Corp Stock (THC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-14 | Ripresa | Goldman | Buy |
| 2025-07-28 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2025-05-29 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-04-15 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2025-03-26 | Iniziato | Morgan Stanley | Overweight |
| 2025-02-26 | Iniziato | TD Cowen | Buy |
| 2024-12-17 | Ripresa | JP Morgan | Overweight |
| 2024-12-16 | Downgrade | Goldman | Buy → Neutral |
| 2024-11-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-11-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2024-10-11 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2024-05-30 | Iniziato | Robert W. Baird | Outperform |
| 2024-03-27 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2024-03-06 | Iniziato | Barclays | Overweight |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-04-19 | Iniziato | JP Morgan | Overweight |
| 2022-06-17 | Iniziato | Loop Capital | Buy |
| 2022-03-29 | Iniziato | Wells Fargo | Overweight |
| 2022-02-10 | Aggiornamento | UBS | Neutral → Buy |
| 2022-02-09 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2022-02-09 | Aggiornamento | Truist | Hold → Buy |
| 2022-01-20 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2022-01-10 | Ripresa | Citigroup | Buy |
| 2021-09-27 | Iniziato | SVB Leerink | Mkt Perform |
| 2021-09-24 | Iniziato | UBS | Neutral |
| 2021-08-12 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2021-07-23 | Ripresa | Citigroup | Buy |
| 2021-07-09 | Iniziato | Seaport Global Securities | Buy |
| 2021-05-03 | Ripresa | Goldman | Buy |
| 2021-01-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2021-01-05 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-12-15 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2020-09-21 | Downgrade | JP Morgan | Neutral → Underweight |
| 2020-03-11 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-02-26 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2019-12-09 | Aggiornamento | UBS | Neutral → Buy |
| 2019-11-06 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2019-08-14 | Ripresa | Goldman | Neutral |
| 2019-02-26 | Reiterato | BofA/Merrill | Neutral |
| 2019-01-14 | Iniziato | Stephens | Equal-Weight |
| 2019-01-03 | Iniziato | Deutsche Bank | Hold |
| 2018-12-17 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2018-11-16 | Iniziato | UBS | Neutral |
| 2018-06-29 | Downgrade | Jefferies | Buy → Hold |
| 2018-03-23 | Ripresa | Mizuho | Buy |
| 2018-01-30 | Ripresa | Wells Fargo | Market Perform |
| 2018-01-03 | Iniziato | Goldman | Neutral |
| 2017-12-20 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2017-12-19 | Reiterato | Mizuho | Neutral |
| 2017-12-14 | Downgrade | JP Morgan | Neutral → Underweight |
| 2017-12-12 | Aggiornamento | Citigroup | Neutral → Buy |
Mostra tutto
Tenet Healthcare Corp Borsa (THC) Ultime notizie
Tenet Healthcare Q1 2026 slides: EPS beats amid deleveraging push - Investing.com
Earnings call transcript: Tenet Healthcare posts strong Q1 2026 EPS beat - Investing.com Canada
Tenet Healthcare (THC) Principal Accounting Officer reports 2,584 RSUs on Form 3 - Stock Titan
Why Tenet Healthcare (THC) is a top value stock for the long term - MSN
Why some Belleville-area hospitals are missing from new safety reports - AOL.com
THC Beats Q1 Earnings Estimates on Strong Ambulatory Growth, Ups '26 EPS View - Yahoo Finance
Here is What to Know Beyond Why Tenet Healthcare Corporation (THC) is a Trending Stock - Yahoo Finance
Tenet to Participate in the BofA Securities Health Care Conference - Yahoo! Finance Canada
MSN Money - MSN
Columbia Select Small Cap Value Fund's Tenet Healthcare Corp(THC) Holding History - GuruFocus
Is It Too Late To Consider Tenet Healthcare (THC) After Its Strong Multi‑Year Rally? - Yahoo Finance
THC Maintained by Stephens & Co. -- Price Target Lowered to $260 - GuruFocus
Earnings call transcript: Tenet Healthcare beats Q1 2026 EPS expectations - Investing.com
EDGAR Filing Documents for 0001193125-17-094187 - SEC.gov
Tenet Healthcare (NYSE:THC) Upgraded to Strong-Buy at Wall Street Zen - MarketBeat
THC Q1 Deep Dive: Hospital Margins Improve Despite Exchange Headwinds and Flat Volumes - Yahoo Finance
Tenet Healthcare Q1 Earnings Call Highlights - MarketBeat
Tenet Healthcare Corp (NYSE:THC) Emerges as a Decent Value Candidate with Strong Fundamentals - ChartMill
Tenet Healthcare Shines In Q1 2026 Earnings Call - The Globe and Mail
THC Maintained by RBC Capital -- Price Target Lowered to $236 - GuruFocus
THC Maintains Overweight Rating by Wells Fargo -- Price Target L - GuruFocus
Is Tenet Healthcare Corp (THC) Overvalued After 3.5% Rally? GF V - GuruFocus
Tenet Healthcare (NYSE:THC) Price Target Cut to $236.00 by Analysts at Royal Bank Of Canada - MarketBeat
THC Maintained by Keybanc -- Price Target Lowered to $225 - GuruFocus
Tenet Healthcare (NYSE:THC) Given New $252.00 Price Target at Guggenheim - MarketBeat
Wells Fargo & Company Issues Pessimistic Forecast for Tenet Healthcare (NYSE:THC) Stock Price - MarketBeat
KeyCorp Lowers Tenet Healthcare (NYSE:THC) Price Target to $225.00 - MarketBeat
Brokers Suggest Investing in Tenet (THC): Read This Before Placing a Bet - Yahoo Finance
Tenet Healthcare Corporation (NYSE:THC) Q1 2026 Earnings Call Transcript - Insider Monkey
Cost management, outpatient unit helped Tenet weather volume headwinds in Q1 - Yahoo Finance
KeyBanc lowers Tenet Healthcare stock price target on valuation - Investing.com
KeyBanc lowers Tenet Healthcare stock price target on valuation By Investing.com - Investing.com UK
Tenet Healthcare Corp (THC) Q1 2026 Earnings Call Highlights: St - GuruFocus
Tenet Healthcare (NYSE:THC) Posts Earnings Results, Beats Expectations By $0.63 EPS - MarketBeat
Tenet Healthcare Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
Net income surges at Tenet Healthcare (NYSE: THC) on CHI contract exit - Stock Titan
Tenet Healthcare Blames Admissions Mix For Soft Q1 Sales - Benzinga
Vanguard files Schedule 13G: Tenet Healthcare (NYSE: THC) 5.26% stake - Stock Titan
Tenet Healthcare Q1 2026 slides: EBITDA beats, USPI growth continues - Investing.com
Earnings call transcript: Tenet Healthcare’s Q1 2026 EPS beats, stock dips - Investing.com
Tenet (THC) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Transcript: Tenet Healthcare Q1 2026 Earnings Conference Call - Benzinga
Tenet Healthcare (NYSE:THC) Updates FY 2026 Earnings Guidance - MarketBeat
Q1 2026 Tenet Healthcare Corp Earnings Call Transcript - GuruFocus
Tenet Healthcare (THC) Reports Q1 Earnings, EPS Beats Expectatio - GuruFocus
Is Tenet Healthcare (THC) Overvalued After Q1 2026? GAAP EPS $8. - GuruFocus
Tenet Healthcare (THC) Confirms FY26 Adjusted EBITDA Forecast - GuruFocus
Tenet Healthcare Releases Q1 2026 Financial Results - AlphaStreet
Tenet Healthcare (THC) Q1 Earnings Top Estimates - Yahoo Finance
Tenet Healthcare (NYSE:THC) Posts Q1 CY2026 Sales In Line With Estimates - Barchart.com
Tenet Healthcare beats profit estimates despite revenue miss - Investing.com
Tenet Healthcare Corp Azioni (THC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.22%
0.98%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):